Promax Scientific Developers Private Limited
About Promax Scientific Developers Private Limited
Data last updated:
Promax Scientific Developers Private Limited is a private limited company based in Nagpur, Maharashtra, India. It operates in the preventive healthcare segment of the healthcare sector. It was incorporated on 07 August 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U80904MH2013PTC246742. Its GSTIN is 27AAHCP3088P1ZN (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Sameer Yeshwant Mardikar and Nitin Balkrishna Bodhale.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No 301 Royal Plaza Appartment Plot No 37 – 2 Tikekar Road Dhantoli, Nagpur, Maharashtra, India – 440012.
As per the financials filed for FY 2025, the company reported a revenue of ₹34.91 Cr, a growth of 31% compared to the previous year. For the same year it recorded a net profit of ₹60.87 Lakh (net margin 1.7%) and EBITDA of ₹1.66 Cr (EBITDA margin 4.8%). Revenue has grown at a compounded annual rate (CAGR) of 122% over three years and 17% over five years.
The company has about 30 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Promax HD Events. As per MCA filings, the company has open charges of ₹3.01 Cr and satisfied charges of ₹76 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressFlat No 301 Royal Plaza Appartment Plot No 37 – 2 Tikekar Road Dhantoli, Nagpur, Maharashtra, India – 440012
- IndustryHealthcare, Preventive Health Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Promax Scientific Developers Private Limited
The main business activity of Promax Scientific Developers is professional, scientific and technical. In detail, this covers scientific research and development.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Promax Scientific Developers Private Limited FY 2025 filings available
Promax Scientific Developers Private Limited reported revenue of ₹34.91 Cr (up 31% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Promax Scientific Developers Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 17% over five years, including 31% growth in the latest year. EBITDA rose 66% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Promax Scientific Developers Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.66 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹60.87 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Promax Scientific Developers Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Promax Scientific Developers are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Promax Scientific Developers Private Limited
Promax Scientific Developers Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Preventive Healthcare Services). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Gowelnext Solutions Private Limited | ₹36.01 Cr (FY 2025) | •••• | •••• | 5.0% | •••• | Bangalore, Karnataka, India |
| Dr. Ramalinga Reddy Maxivision Eye Hospitals Private Limited | ₹35.83 Cr (FY 2025) | •••• | •••• | 21.0% | •••• | Guntur, Andhra Pradesh, India |
| Timila Vanijya Private Limited | ₹35.58 Cr (FY 2025) | •••• | •••• | 19.0% | •••• | North 24 Parganas, West Bengal, India |
| Alkem Foundation | ₹35.31 Cr (FY 2025) | •••• | •••• | -34.0% | •••• | Mumbai, Maharashtra, India |
| Shalby Medtech Limited | ₹35.2 Cr (FY 2025) | •••• | •••• | 125.0% | •••• | Ahmedabad, Gujarat, India |
| Promax Scientific Developers Private Limited this company | ₹34.91 Cr (FY 2025) | •••• | •••• | 31.0% | •••• | Nagpur, Maharashtra, India |
| Bharath Healthcare Laboratories Private Limited | ₹34.67 Cr (FY 2024) | •••• | •••• | 12.0% | •••• | Hyderabad, Telangana, India |
| Vision Dempo Hospitality and Estates Private Limited | ₹34.05 Cr (FY 2025) | •••• | •••• | 9.0% | •••• | Panaji, Goa, India |
| Crystal Medical Centre Private Limited | ₹33.87 Cr (FY 2025) | •••• | •••• | 15.0% | •••• | Kanpur, Uttar Pradesh, India |
| Mirra Health Care Services India Private Limited | ₹33.51 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | New Delhi, Delhi, India |
| Kukreja Hospital & Heart Centre Private Limited | ₹32.77 Cr (FY 2024) | •••• | •••• | 23.0% | •••• | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below Promax Scientific Developers by revenue in the Healthcare industry (Preventive Healthcare Services), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Promax Scientific Developers Private Limited
Promax Scientific Developers Private Limited is audited by P.S. DONGRE & CO for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| P.S. DONGRE & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Promax Scientific Developers Private Limited
Promax Scientific Developers has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sameer Yeshwant Mardikar | Director | 07 Aug 2013 | 13 Years 2 Months | Current |
| Nitin Balkrishna Bodhale | Director | 07 Aug 2013 | 13 Years 2 Months | Current |
Ownership and Shareholding of Promax Scientific Developers Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Promax Scientific Developers Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Feb 2024 | State Bank of India | ₹2 Cr | Open |
| 09 Nov 2023 | Axis Bank Limited | ₹68 Lakh | Open |
| 07 Nov 2023 | Axis Bank Limited | ₹33.3 Lakh | Open |
| 24 Jan 2019 | State Bank of India | ₹76 Lakh | Satisfied |
Total charge records: 4 View all charges
Associated Brands with Promax Scientific Developers Private Limited
Promax Scientific Developers operates one associated brand: Promax HD Events. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Event management and AV solutions for medical conferences in India. | promaxhdevents.com |
Employees and EPFO Compliance at Promax Scientific Developers Private Limited
Promax Scientific Developers Private Limited has a workforce of 30 employees as of Nov 29, 2025.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Promax Scientific Developers Private Limited
Promax Scientific Developers Private Limited has 2 board changes on record since 2013: 2 appointments. The latest: Nitin Balkrishna Bodhale was appointed as Director on 07 Aug 2013.
Credit Ratings, Litigation & Regulatory Alerts for Promax Scientific Developers Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Promax Scientific Developers Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Promax Scientific Developers Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Promax Scientific Developers Private Limited
Promax Scientific Developers has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAHCP3088P1ZN | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Promax Scientific Developers Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Promax Scientific Developers Private Limited
Promax Scientific Developers is an active private limited company based in Nagpur, Maharashtra, India. The company works in preventive health services, within the healthcare industry. It was incorporated on 07 August 2013 (13+ years old) and is registered under CIN U80904MH2013PTC246742.
Promax Scientific Developers reported revenue of ₹34.91 Cr for FY 2025 (up 31% YoY).
Promax Scientific Developers has 2 current directors:
- Sameer Yeshwant Mardikar - Director
- Nitin Balkrishna Bodhale - Director
Promax Scientific Developers reported a net profit of ₹60.87 Lakh (net margin 1.7%) and EBITDA of ₹1.66 Cr (EBITDA margin 4.8%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Promax Scientific Developers is 122% over three years and 17% over five years. In the latest year (FY 2025) revenue rose 31%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Promax Scientific Developers is 27AAHCP3088P1ZN, registered in Maharashtra.
The CIN (Corporate Identification Number) of Promax Scientific Developers is U80904MH2013PTC246742. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Promax Scientific Developers was incorporated on 07 August 2013, making it 13+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Promax Scientific Developers by revenue are Gowelnext Solutions Private Limited, Dr. Ramalinga Reddy Maxivision Eye Hospitals Private Limited, Timila Vanijya Private Limited, Alkem Foundation, Shalby Medtech Limited and 5 more, all in the Healthcare industry (Preventive Healthcare Services).
Nitin Balkrishna Bodhale was appointed as Director on 07 Aug 2013. Sameer Yeshwant Mardikar was appointed as Director on 07 Aug 2013.
The registered office of Promax Scientific Developers is at Flat No 301 Royal Plaza Appartment Plot No 37 – 2 Tikekar Road Dhantoli, Nagpur, Maharashtra, India – 440012.